Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice
Noriaki Okamoto, … , Sogo Nishimoto, Takeshi Watanabe
Noriaki Okamoto, … , Sogo Nishimoto, Takeshi Watanabe
Published April 2, 2007
Citation Information: J Clin Invest. 2007;117(4):997-1007. https://doi.org/10.1172/JCI30379.
View: Text | PDF
Research Article Immunology

Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice

  • Text
  • PDF
Abstract

We previously demonstrated that artificial lymph nodes (aLNs) could be generated in mice by the implantation of stromal cell–embedded biocompatible scaffolds into their renal subcapsular spaces. T and B cell domains that form in aLNs have immune response functions similar to those of follicles of normal lymphoid tissue. In the present study, we show that the aLNs were transplantable to normal as well as SCID mice, where they efficiently induced secondary immune responses. Antigen-specific secondary responses were strongly induced in aLNs even 4 weeks after their transplantation. The antigen-specific antibody responses in lymphocyte-deficient SCID mice receiving transplanted aLNs were substantial. The cells from the aLNs migrated to the SCID mouse spleen and BM, where they expanded to generate large numbers of antigen-specific antibody-forming cells. Secondary responses were maintained over time after immunization (i.e., antigen challenge), indicating that aLNs can support the development of memory B cells and long-lived plasma cells. Memory CD4+ T cells were enriched in the aLNs and spleens of aLN-transplanted SCID mice. Our results indicate that aLNs support strong antigen-specific secondary antibody responses in immunodeficient mice and suggest the possibility of future clinical applications.

Authors

Noriaki Okamoto, Risa Chihara, Chiori Shimizu, Sogo Nishimoto, Takeshi Watanabe

×

Figure 6

Enrichment of memory-type (CD44hiCD62Llo) CD4+ T cells in aLNs or spleens of aLN-transplanted SCID mice.

Options: View larger image (or click on image) Download as PowerPoint
Enrichment of memory-type (CD44hiCD62Llo) CD4+ T cells in aLNs or spleen...
(A) FACS plots demonstrating an increase in the CD44hiCD62Llo memory-type CD4+ T cell population in aLNs compared with that in lymph nodes of recipient BALB/c mice. Downward pointing arrows indicate the CD44/CD62L profile of cells within the CD4+ T cell gate. (B) FACS plots demonstrating an increase in the CD44hiCD62Llo memory-type CD4+ T cell population in the spleens of aLN-transplanted SCID mice, regardless of antigen stimulation, compared with that of lymph nodes or spleens in normal BALB/c mouse preimmunized with the same doses of NP-OVA. Numbers in the plots in A and B indicate the percentage of cells within the CD62Llo/CD44+ gate. (C) Immunohistochemical staining of CD127+ T cells in aLNs. Three weeks after aLNs were formed in NP-OVA preimmunized BALB/c mice, aLNs and lymph nodes of recipient BALB/c mice were stained with FITC-labeled anti-mouse CD3, anti-mouse CD127 antibodies, and Alexa Fluor 594–conjugated anti-rat IgG. Most CD3+ T cells were also CD127+.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts